The implications of incomplete and deviant prescriptions extend beyond individual patient experiences to broader healthcare system challenges.... Apr 13
Glenmark's commitment to providing affordable and effective solutions highlights its role as a leader in diabetes care. As Zita DM becomes a part of ... Oct 19
... Feb 02
ALKS 3831 is an investigational, novel, once-daily, oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and for the treatment of ... Dec 29
Gannex, announced today that it received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its non-alcoholic steatohepatitis (NASH) drug ... Dec 14
The import of such drugs may be permitted after taking an undertaking from the importers by the port officers of CDSCO that the drug will ... Apr 20
The Company is also expanding portfolio in lifestyle and chronic segment especially in women healthcare and dermatology to complement its strong presence in the acute ... Mar 09
-Advertisements-
Sunday, May 12, 2024
.jpeg)
